Emir DÖNDER, Mustafa NAZIROĞLU, Gıyasettin BAYDAŞ, Necip İLHAN, Mehmet ÇAY

Effect of selenium on ''low T3 syndrome '' in hepatic failure

Triiodothyronine occurs especially in S'-monodeiodination of thyroxin in peripheral tissues. Deiodination of thyroxin mainly occurs in the liver. The enzyme which catalyzes this reaction is a seleno-enzyme. Deiodinase enzyme activity and the triiodothyronine level decrease in selenium deficiency. After the occurrence of chronic hepatic failure by carbon tetrachloride in rats, we gave sodium selenite to these rats. Then, we tried to evaluate the changes in thyroid hormone levels. Liver function tests, thyroxin and triiodothyronine levels, and hepatic 5'-deiodinase and glutathione peroxidase enzyme activities were measured. Triiodothyronine levels in the carbon tetrachloride group and carbon tetrachloride + selenium group were significantly lower than in the control group (P

PDF

___

1.Coombs GF., Coombs SB. Selenium andCancer. In: Coombs GF., ed. The role ofselenium in nutrition, Academic Press,Orlando, 1986, 413–61.
2.L’Abbe MR., Fischer PWF., Cambelli JS.,Chavez ER. Effects of dietary seleniumon DMBA–induced carcinogenesis inrats fed a diet high in mixed fats. J Nutr119: 757–65, 1989.
3.Halverson AW. Growth andreproduction with rats fed selenite–Se.Proc S Dakota Acad Sci 53: 167–77,1974.
4.Willet WC., Morris JS., Pressel S.,Taylor JO., Polk BF., Stampfer MJ.Prediagnostic serum selenium and riskof cancer. Lancet 2: 130–4, 1985.
5.Har JR., Exon JH., Whanger PD.,Weswig PH. Effect of dietarysupplementation on N–2–fluorenyl–acetamide (FAA)–induced cancer invitamin E supplemented seleniumdepleted rats. Clin Toxicol 5: 187–94,1972.
6.Beckett GJ., Beddows SE., MorricePC., Nicol F., Arthur JR. Inhibition ofhepatic deiodination of thyroxine iscaused by selenium deficiency in rats.Biochem J 248: 443–7, 1987
7.Beckett GJ., Nicol F., Proudfoot D.,Dyson K., Loucaides G., Arthur JR. Thechanges in hepatic enzyme expressioncaused by selenium deficiency andhypothyroidism in rats are produced byindependent mechanisms. Biochem J266: 743–7, 1990.
8.Meinhold H., Campos–Barros A.,Walzog B., Köhler R., Müller F. Effectsof selenium and iodine deficiency ontype I, type II, and type III iodothyroninedeiodinases and circulating thyroidhormone in rats. Exp Clin Endocrinol101: 87–93, 1993.
9.Beckett GJ., Russel A., Nicol F., SahuP., Wolf C., Arthur JR. Effect ofselenium deficiency on hepatic type I5–iodothyronine deiodinase activityand hepatic thyroid hormone level inthe rat. Biochem J 282: 483–6, 1992.
10.Chanoine JP., Safran M., Farwel AP.,Dubord S., Alex S., Stone S. Effects ofselenium deficiency on thyroidhormone economy in rats. Endocrinol131: 1787–92, 1992.
11.Chopra IJ. A study of extrathyroidalconversion by thyroxine (T4) to 3, 3’,5–triiodothyronine (T3) in vitro.Endocrinol 101: 453–63, 1977.
12.Kabadi UM., Premachandra BN. Lowserum T3 and raised reverse T3 levelsin hepatic cirrhosis: role of glucagon. J.Gastroenterol 86: 1504–7, 1991.
13.Arthur JR., Morrice PC., Nicol F.,Beddows SE., Boyd R., Hayes JD.,Beckett GJ. The effects of selenium andcopper deficiencies on glutathioneS–transferase and glutathioneperoxidase in rat liver. Biochem J 248:539–44, 1987.
14.Burman KD., Smallridge RC., Jones L.,Ramos EA. Glucagon kinetics infasting: Physiological elevation inserum 3, 5, 3’–triiodothyronineincrease the metabolic clearence rate ofglucagon. J Clin Endocrinol Metab 51:1158–65, 1980.
15.O’Connel M., Robbins DC., Horton ES.,Sims EA., Danforth E. Changes inserum concentration of 3, 3’,5–triiodothyronine and 3, 5,3’–triiodothyronine during prolongedmoderate exercise. J Clin EndocrinolMetab 49: 242–6, 1979.
16.Kabadi UM., Einstein AB., Tucci J.Hyperglucagonemia in hepaticcirrhosis: Its relation to hepatocellulardysfunction and normalization onrecovery. J Gastroenterol 790: 143–9,1984.
17.Bernardi M., Rossane P., Trevisani F.,Pesa O. “Low T3 syndrome” incirrhosis: Effect of beta–blockade. JGastroenterol 84: 727–31, 1989.
18.Kabadi UM., Premachandra BN. SerumT3 and reverse T3 levels in hepaticcirrhosis: Relation on hepatocellulardamage and normalization onimprovement in liver dysfunction. J.Gastroenterol 78: 750–5, 1983.
19.Chopra IJ., Chopra U., Smith SR., RezaM., Solomon DH. Reciprocal changesin serum concentrations of 3, 3’,5–triiodothyronine (reserve T3) and 3,5, 3’–triiodothyronine (T3) in systemicillnesses. J Clin Endocrinol Metab 41:1043–9, 1975.
20.Kabadi UM., Premachandra BN.Glucagon administration induceslowering of serum T3 and rise inreserve T3 in euthyroid healthysubjects. Horm Metabol Res 17:667–70, 1985.
21.Arthur JR., Nicol F., Becket GJ. Hepaticiodothyronine 5’–deiodinase: Role ofselenium. Biochem J 272: 537–40,1990.
22.Chanoine JP., Safran M., Farwell AP.,Tranter P. Selenium deficiency and typeII 5’–deiodinase regulation in theeuthyroid and hypothyroid rat:Evidence of a direct effect of thyroxine.Endocrinol 131: 479–84, 1992.
23.Beckett GJ., MacDougall DA., Nicol F.,Arthur JR., Inhibition of type I and typeII iodothyronine deiodinase activity inrat liver, kidney, and brain produced byselenium deficiency. Biochem J 259:887–92, 1989.